Shenzhen Chipscreen Biosciences Ltd.

Drug discovery company specialised in novel small molecule therapeutics; lead discovery and optimisation of transcription modulators for type II diabetes, cancer, and osteoporosis, services including assay development, microarray analysis and combinatorial chemistry

Chipscreen Biosciences was established on 21 March 2001 in Shenzhen with an initial capital of USD 5.8 million from investors across Asia.

Xian-Ping Lu (President, CSO)
Zhiqiang Ning (Co-founder and R&D Director)
Weiming Hu (Co-founder)
Leming Shi (Co-founder)

David Sun (Chairman)

Suite C301
P.O. Box 28
Research Institute of Tsinghua University
High-Tech Park, Nanshan District
518057 Shenzhen, Guangdong Province
P. R. China
Phone: +86-755-26957779
Fax: +86-755-26957291

Chemogenomics-based integrated drug discovery platform